Fig. 10From: Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulationsRMSF graph for the residues of 10h/BRAFWT (orange) and 10h/BRAFV600E (blue) structures during 100 ns MD simulationBack to article page